相关实验视频

Updated: Jun 29, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Published on: February 15, 2022

败血症相关的急性损伤:我们现在在哪里?

Dimitris Kounatidis¹, Natalia G Vallianou¹, Sotiria Psallida²

¹Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str., 10676 Athens, Greece.

Medicina (Kaunas, Lithuania)

|March 28, 2024

概括

败血症相关的急性损伤 (SA-AKI) 涉及诸如炎症和细胞死亡等复杂的机制,影响患者的治疗结果. 研究探讨了新的生物标志物和治疗目标,以更好地管理SA-AKI.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
关键护理医学关键护理医学
分子生物学分子生物学

背景情况:

败血症是全球死亡的主要原因,败血症相关的急性损伤 (SA-AKI) 导致高达70%的AKI病例复杂化.
根据KDIGO标准在败血症期间定义的SA-AKI,表现为早期 (48小时内) 或晚期 (48小时-7天),并且与预后较差有关.
了解SA-AKI的多样化表型和病理生理路径对于改善患者的治疗结果至关重要.

研究的目的:

提供SA-AKI发展背后的致病基因机制的最新审查.
分析与SA-AKI相关的不同表型和预后.
讨论SA-AKI的新型诊断/预后生物标志物和潜在的治疗策略.

主要方法:

关于SA-AKI病原体,表型和生物标志物的当前文献的综述.
分析涉及的分子和细胞机制,包括炎症,细胞死亡和血液动力学变化.
探索omics技术和机器学习,以获得SA-AKI综合洞察力.

主要成果:

SA-AKI的发病包括炎症,代谢重编程,多种类型的细胞死亡 (亡,亡,热亡,铁亡),自,血细胞分裂和血液动力功能障碍.
许多血清和尿路生物标记物 (例如IL-6,NGAL,cystatin C,TIMP-2) 和新型的欧米基衍生标记物 (lncRNAs,miRNAs) 显示出诊断和预后潜力.
存在不同的SA-AKI表型,需要量身定制的诊断和治疗方法.

结论:

综合性奥米克斯方法提供了SA-AKI的整体观点,有助于破译特定的表型.
新型生物标志物和治疗点,包括lncRNAs和miRNAs,对早期诊断,风险预后和个性化的SA-AKI管理具有前景.
需要进一步的研究来验证这些发现,并将其转化为临床实践,以革新SA-AKI护理.

关键词:

急性脏损伤急性脏损伤是什么生物标志物生物标志物感染的感染感染.这是一种血症.与败血症相关的急性损伤败血症的冲击是一个令人震惊的现象.治疗疗法治疗疗法治疗疗法

更多相关视频

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

相关概念视频

Nephrons

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...